Literature DB >> 15636614

A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity.

Martin S Zand1, Anirban Bose, Thuong Vo, Myra Coppage, Tina Pellegrin, Lois Arend, F Eun-Hyung Lee, Adel Bozorgzadeh, Nufatt Leong.   

Abstract

A major impediment to repetitive monitoring of alloreactivity or tolerance is the limited supply of donor cells available for assays of host-versus-graft T- and B-cell reactivity. In this paper, we describe the use of CD40L stimulated CD19(+) B cells as targets or stimulators in flow cytometric crossmatching (FXM), mixed lymphocyte reactivity and IFN-gamma ELISPOT assays. Stimulated B cells (sBc) express high levels of MHC class I and II, as well as the costimulatory molecules CD80 and CD86. They can be polyclonally expanded and frozen for later use. We describe the use of sBc in ELISPOT, mixed lymphocyte cultures and FXM. CD4(+) T cells exposed to sBc express a similar cytokine profile as those stimulated with unfractionated PBMC. We further analyzed T- and B-cell responses in 14 patients on the renal transplant waiting list, finding that those with an elevated panel reactive antibody (PRA) (>60%) had higher alloreactive T-cell precursor frequencies as measured by CDFSE MLR and IFN-gamma ELISPOT. We conclude that sBc are a renewable source of donor-specific target/stimulator cells for use in repetitive and coordinate assays of B- and T-cell alloreactivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15636614     DOI: 10.1111/j.1600-6143.2003.00637.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

2.  Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

Authors:  Martin S Zand; Thuong Vo; Tina Pellegrin; Raymond Felgar; Jane L Liesveld; Jainulabdeen J Ifthikharuddin; Camille N Abboud; Ignacio Sanz; Jennifer Huggins
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

3.  Immunosuppressive effects of the traditional Chinese herb Qu Mai on human alloreactive T cells.

Authors:  J Reid-Adam; N Yang; Y Song; P Cravedi; X-M Li; P Heeger
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

Review 4.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

5.  T cells in patients with narcolepsy target self-antigens of hypocretin neurons.

Authors:  Daniela Latorre; Ulf Kallweit; Eric Armentani; Mathilde Foglierini; Federico Mele; Antonino Cassotta; Sandra Jovic; David Jarrossay; Johannes Mathis; Francesco Zellini; Burkhard Becher; Antonio Lanzavecchia; Ramin Khatami; Mauro Manconi; Mehdi Tafti; Claudio L Bassetti; Federica Sallusto
Journal:  Nature       Date:  2018-09-19       Impact factor: 49.962

6.  Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.

Authors:  L Cherkassky; M Lanning; P N Lalli; J Czerr; H Siegel; L Danziger-Isakov; T Srinivas; A Valujskikh; D A Shoskes; W Baldwin; R L Fairchild; E D Poggio
Journal:  Am J Transplant       Date:  2011-05-12       Impact factor: 8.086

7.  Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients.

Authors:  Paolo Cravedi; Miguel Fribourg; Weijia Zhang; Zhengzi Yi; Elena Zaslavsky; German Nudelman; Lisa Anderson; Susan Hartzell; Sophie Brouard; Peter S Heeger
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

8.  Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma.

Authors:  Lynn F Sniderhan; Tatiana M Garcia-Bates; Michael Burgart; Steven H Bernstein; Richard P Phipps; Sanjay B Maggirwar
Journal:  Exp Hematol       Date:  2009-08-28       Impact factor: 3.084

9.  Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.

Authors:  D E Hricik; J Augustine; P Nickerson; R N Formica; E D Poggio; D Rush; K A Newell; J Goebel; I W Gibson; R L Fairchild; K Spain; D Iklé; N D Bridges; P S Heeger
Journal:  Am J Transplant       Date:  2015-07-30       Impact factor: 8.086

10.  Effects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation.

Authors:  Donald E Hricik; Emilio D Poggio; Kenneth J Woodside; Naragaju Sarabu; Edmund Q Sanchez; James A Schulak; Aparna Padiyar; Peter S Heeger; Joshua J Augustine
Journal:  Transplantation       Date:  2013-05-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.